Can I read HDAC2 As A Therapeutic Target in Bladder Cancer on EtoBox?

HDAC2 As A Therapeutic Target in Bladder Cancer by xyz48753 is a document available to read on EtoBox.

What is HDAC2 As A Therapeutic Target in Bladder Cancer about?

The study investigates the role of HDAC2 in bladder cancer (BCa), highlighting its overexpression as a promoter of malignancy and chemoresistance through altered epigenetic regulation and lysine lactylation. Functional assays and proteomic analyses revealed that HDAC2 significantly impacts cell proliferation, metastasis, and the regulation of key proteins involved in splicing. The findings position HDAC2 as a promising therapeutic target for developing precision therapies in BCa.

Author

xyz48753

Language

EN